A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 22, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Overweight or Obesity
Interventions
DRUG

Xenical® vs EMP 22

Each participant will first use Xenical® TID for 9 days and then EMP22TID for 9 days (in total 27 doses of each drug).

DRUG

EMP 22 vs Xenical®

Each participant will first use EMP22 TID for 9 days and then Xenical® TID for 9 days (in total 27 doses of each drug).

DRUG

EMP 16 vs Xenical®

Each participant will receive a single dose of EMP16 and then a single dose of Xenical®.

Trial Locations (1)

752 37

RECRUITING

CTC Clinical Trial Consultanta AB, Uppsala

Sponsors
All Listed Sponsors
collaborator

CTC Clinical Trial Consultants AB

INDUSTRY

lead

Empros Pharma AB

INDUSTRY